Targeting EGFR signalling pathway in triple negative breast cancer
<p>Epidermal growth factor receptor (EGFR) is frequently overexpressed in the majority of triple negative breast cancer patients (TNBC). However, the molecular determinants behind their limited response to EGFR-targeted therapies are poorly understood. Here, both the acute and chronic response...
| Váldodahkki: | |
|---|---|
| Eará dahkkit: | |
| Materiálatiipa: | Oahppočájánas |
| Giella: | English |
| Almmustuhtton: |
2014
|
| Fáttát: |